m6A Methyltransferase METTL3 Reduces Hippocampal Neuron Apoptosis in a Mouse Model of Autism Through the MALAT1/SFRP2/Wnt/β-catenin Axis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective Hippocampal neuron apoptosis contributes to autism, while METTL3 has been documented to possess great potentials in neuron apoptosis. Our study probed into the role of METTL3 in neuron apoptosis in autism and to determine the underlying mechanism.Methods Bioinformatics analysis was used to analyze expressed genes in autism samples. Institute of Cancer Research mice were treated with valproic acid to develop autism models. The function of METTL3 in autism-like symptoms in mice was analyzed with behavioral tests and histological examination of their hippocampal tissues. Primary mouse hippocampal neurons were extracted for in vitro studies. Downstream factors of METTL3 were explored and validated.Results METTL3, MALAT1, and Wnt/β-catenin signaling were downregulated, while SFRP2 was upregulated in the hippocampal tissues of a mouse model of autism. METTL3 stabilized MALAT1 expression by promoting m6A modification of MALAT1. MALAT1 promoted SFRP2 methylation and led to reduced SFRP2 expression by recruiting DNMT1, DNMT3A, and DNMT3B to the promoter region of SFRP2. Furthermore, SFRP2 facilitated activation of the Wnt/β-catenin signaling. By this mechanism, METTL3 suppressed autism-like symptoms and hippocampal neuron apoptosis.Conclusion This research suggests that METTL3 can reduce autism-like symptoms and hippocampal neuron apoptosis by regulating the MALAT1/SFRP2/Wnt/β-catenin axis.
Abstract
Objective Hippocampal neuron apoptosis contributes to autism, while METTL3 has been documented to possess great potentials in neuron apoptosis. Our study probed into the role of METTL3 in neuron apoptosis in autism and to determine the underlying mechanism.Methods Bioinformatics analysis was used to analyze expressed genes in autism samples. Institute of Cancer Research mice were treated with valproic acid to develop autism models. The function of METTL3 in autism-like symptoms in mice was analyzed with behavioral tests and histological examination of their hippocampal tissues. Primary mouse hippocampal neurons were extracted for in vitro studies. Downstream factors of METTL3 were explored and validated.Results METTL3, MALAT1, and Wnt/β-catenin signaling were downregulated, while SFRP2 was upregulated in the hippocampal tissues of a mouse model of autism. METTL3 stabilized MALAT1 expression by promoting m6A modification of MALAT1. MALAT1 promoted SFRP2 methylation and led to reduced SFRP2 expression by recruiting DNMT1, DNMT3A, and DNMT3B to the promoter region of SFRP2. Furthermore, SFRP2 facilitated activation of the Wnt/β-catenin signaling. By this mechanism, METTL3 suppressed autism-like symptoms and hippocampal neuron apoptosis.Conclusion This research suggests that METTL3 can reduce autism-like symptoms and hippocampal neuron apoptosis by regulating the MALAT1/SFRP2/Wnt/β-catenin axis.
참고문헌 (47)
- Anitha A, "MicroRNA and autism", Adv Exp Med Biol, 888, pp.71~83 (2015)
- Baron-Cohen S, "Why are autism spectrum conditions more prevalent in males?", PLoS Biol, 9, pp.e1001081~ (2011)
- Elder JH, "Clinical impact of early diagnosis of autism on the prognosis and parent-child relationships", Psychol Res Behav Manag, 10, pp.283~292 (2017)
- Chaste P, "Autism risk factors: genes, environment, and gene-environment interactions", Dialogues Clin Neurosci, 14, pp.281~292 (2012)
- You YH, "MicroRNA-153 promotes brain-derived neurotrophic factor and hippocampal neuron proliferation to alleviate autism symptoms through inhibition of JAKSTAT pathway by LEPR", Biosci Rep, 39 (2019)
- Zhang C, "YTHDF2promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation", Oncogene, 39, pp.4507~4518 (2020)
- Geng Y, "Identification of m6A-related genes and m6A RNA methylation regulators in pancreatic cancer and their association with survival", Ann Transl Med, 8, pp.387~ (2020)
- Slobodin B, "Transcription dynamics regulate poly(A) tails and expression of the RNA degradation machinery to balance mRNA levels", Mol Cell, 78, pp.434~444.e5 (2020)
- Yang J, "N(6)-methyladenosine METTL3 modulates the proliferation and apoptosis of lens epithelial cells in diabetic cataract", Mol Ther Nucleic Acids, 20, pp.111~116 (2020)
- Yoon KJ, "Temporal control of mammalian cortical neurogenesis by m(6)A methylation", Cell, 171, pp.877~889.e17 (2017)
- Li S, "Effect of m6A methyltransferase METTL3-mediated MALAT1", E2F1, J Biochem Mol Toxicol, pp.2022, 36[DOI]
- Liu C, "LncRNA MALAT1 promoted high glucose-induced pyroptosis of renal tubular epithelial cell by sponging miR-30c targeting for NLRP3", Kaohsiung J Med Sci, 36, pp.682~691 (2020)
- Gong A, "The carcinogenic complex lncRNA DUXAP8", EZH2, J BUON, pp.2019, 24[DOI]
- Sun M, "LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1, and DNMT1", Cancer Res, 76, pp.6299~6310 (2016)
- Alex AM, "Genetic association of DNMT variants can play a critical role in defining the methylation patterns in autism", IUBMB Life, 71, pp.901~907 (2019)
- van Loon K, "Secreted frizzled-related protein 2: a key player in noncanonical Wnt signaling and tumor angiogenesis", Cancer Metastasis Rev, 40, pp.191~203 (2021)
- Zhou M, "sFRP2 promotes airway inflammation and Th17", Treg imbalance in COPD via Wnt, Respir Physiol Neurobiol, pp.2019, 270[DOI]
- Lang H, "Linc-FOXD3 knockdown enhances hippocampal NSCs activation through upregulation of the Wnt", beta-catenin pathway, 2020, pp.729, 134991~
- Szklarczyk D, "The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible", Nucleic Acids Res, 45, pp.D362~D368 (2017)
- Bader GD, "An automated method for finding molecular complexes in large protein interaction networks", BMC Bioinformatics, 4, pp.2~ (2003)
- Chen K, "Therapeutic effects of the in vitro cultured human gut microbiota as transplants on altering gut microbiota and improving symptoms associated with autism spectrum disorder", Microb Ecol, 80, pp.475~486 (2020)
- Liu S, "Induction of neuronal PI3Kgamma contributes to endoplasmic reticulum stress and longterm functional impairment in a murine model of traumatic brain injury", Neurotherapeutics, 16, pp.1320~1334 (2019)
- Lv X, "MicroRNA-27a-3p suppression of peroxisome proliferator-activated receptor-γ contributes to cognitive impairments resulting from sevoflurane treatment", J Neurochem, 143, pp.306~319 (2017)
- Weng YL, "Epitranscriptomic m(6)A Regulation of Axon Regeneration in the Adult Mammalian Nervous System", Neuron, 97, pp.313~325.e6 (2018)
- Jin D, "m(6)A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis", J Hematol Oncol, 12, pp.135~ (2019)
- Shi H, "m(6)A facilitates hippocampus-dependent learning and memory through YTHDF1", Nature, 563, pp.249~253 (2018)
- Brodie SA, "Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer", Cancer Prev Res (Phila), 7, pp.351~361 (2014)
- Liu Y, "β-Catenin, a transcription factor activated by canonical wnt signaling, is expressed in sensory neurons of calves latently infected with bovine herpesvirus 1", J Virol, 90, pp.3148~3159 (2016)
- Li T, "DIXDC1 prevents oxygen-glucose deprivation", reoxygenation-induced injury in hippocampal neurons in vitro by promoting Wnt, Eur Rev Med Pharmacol Sci, pp.2018, 22[DOI]
- Yuan Y, "The M6A methyltransferase METTL3promotes the development and progression of prostate carcinoma via mediating MYC methylation", J Cancer, 11, pp.3588~3595 (2020)
- Meng QZ, "METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2", Eur Rev Med Pharmacol Sci, 24, pp.4328~4336 (2020)
- Svobodová Kovaříková A, "N(6)-Adenosine methylation in RNA and a reduced m3G", TMG level in non-coding RNAs appear at microirradiation-induced DNA lesions, 2020, pp.9, 360~
- Schupp T, "Hypokalemia but not hyperkalemia is associated with recurrences of ventricular tachyarrhythmias in ICD recipients", Clin Lab, 66 (2020)
- Chang YZ, "METTL3enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-kappaB to promote the malignant progression of IDH-wildtype glioma", Cancer Lett, 511, pp.36~46 (2021)
- Piras IS, "Molecular biomarkers to track clinical improvement following an integrative treatment model in autistic toddlers", Acta Neuropsychiatr, 33, pp.267~272 (2021)
- Ma R, "LncRNA MALAT1 knockdown inhibits cell migration and invasion by suppressing autophagy through miR-384", GOLM1 axis in glioma, 2020, pp.24, 2601~2615
- Shan TD, "Downregulation of lncRNA MALAT1suppresses abnormal proliferation of small intestinal epithelial stem cells through miR-129-5p expression in diabetic mice", Int J Mol Med, 45, pp.1250~1260 (2020)
- Zhang YF, "Propofol facilitates cisplatin sensitivity via lncRNA MALAT1", miR-30e, Life Sci, pp.2020, 244[DOI]
- Piras IS, "Huntingtin gene CAG repeat size affects autism risk: familybased and case-control association study", Am J Med Genet B Neuropsychiatr Genet, 183, pp.341~351 (2020)
- Bjørklund G, "The role of glutathione redox imbalance in autism spectrum disorder: a review", Free Radic Biol Med, 160, pp.149~162 (2020)
- Shi YL, "Influence of lncRNA-MALAT1 on neuronal apoptosis in rats with cerebral infarction through regulating the ERK", MAPK signaling pathway, 2019, pp.23, 8039~8048
- Lin R, "Naringin induces endoplasmic reticulum stress-mediated apoptosis, inhibits β-catenin pathway and arrests cell cycle in cervical cancer cells", Acta Biochim Pol, 67, pp.181~188 (2020)
- Yuan S, "Role of Wnt", β-catenin signaling in the chemoresistance modulation of colorectal cancer, 2020, pp.2020, 9390878~
- Xia W, "MicroRNA-423 drug resistance and proliferation of breast cancer cells by targeting ZFP36", Onco Targets Ther, 13, pp.769~782 (2020)
- Vallée A, "PPAR γ agonists: potential treatment for autism spectrum disorder by inhibiting the canonical WNT", β-catenin pathway, 2019, pp.24, 643~652
- Duan H, "TET1 inhibits EMT of ovarian cancer cells through activating Wnt", β-catenin signaling inhibitors DKK1 and SFRP2, 2017, pp.147, 408~417
- Jin L, "SFRP2 enhances the osteogenic differentiation of apical papilla stem cells by antagonizing the canonical WNT pathway", Cell Mol Biol Lett, 22, pp.14~ (2017)
